Abstract

Intravascular large B-cell lymphoma (IVLBCL) is a rare form of diffuse LBCL. The patient was a 71-year-old female admitted to our hospital with hypoxia. On admission, chest computed tomography revealed a ground-glass opacity. Interstitial pneumonia associated with systemic scleroderma was suspected because of positive anti-centromere antibody. Thereafter, steroid pulse therapy and plasma exchange were performed. Although ground-glass opacity improved, bilateral pleural effusion appeared, so we performed a random skin biopsy because of her elevated serum lactate dehydrogenase and soluble interleukin-2 receptor levels. The patient was diagnosed with IVLBCL with symptoms improving after 6 cycles of rituximab plus chemotherapy treatment.

Highlights

  • The World Health Organization classification defines intravascular diffuse large B-cell lymphoma (IVLBCL) as a rare subtype of non-Hodgkin’s lymphoma, where neoplastic cells grow mainly in the lumina of small vessels.[1]

  • We report an IVLBCL case with ground-glass opacity (GGO) of the bilateral lungs and anti-centromere antibody positivity in blood tests, which required distinction from interstitial pneumonia related to collagen disease

  • Our IVLBCL case needed to be differentiated from interstitial pneumonia related to systemic scleroderma with positive anti-centromere antibody because their clinical courses are quite similar and due to some reports on malignant lymphoma associated autoimmune disease.[6]

Read more

Summary

Introduction

The World Health Organization classification defines intravascular diffuse large B-cell lymphoma (IVLBCL) as a rare subtype of non-Hodgkin’s lymphoma, where neoplastic cells grow mainly in the lumina of small vessels.[1]. We report an IVLBCL case with ground-glass opacity (GGO) of the bilateral lungs and anti-centromere antibody positivity in blood tests, which required distinction from interstitial pneumonia related to collagen disease.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call